• Wed, April 10, 2024
Josh Schimmer Reiterated (XENE) at Buy and Held Target at $65 on, Apr 10th, 2024
Josh Schimmer of Cantor Fitzgerald, Reiterated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $65 on, Apr 10th, 2024.
Josh has made no other calls on XENE in the last 4 months.
There are 6 other peers that have a rating on XENE. Out of the 6 peers that are also analyzing XENE, 0 agree with Josh's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Josh
- Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $55 on, Friday, March 1st, 2024
- Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $51 on, Friday, March 1st, 2024
- Serge Belanger of "Needham" Maintained at Strong Buy with Increased Target to $62 on, Friday, March 1st, 2024
- David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $62 on, Thursday, January 4th, 2024
- Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $56 on, Tuesday, January 2nd, 2024
- Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $62 on, Monday, December 18th, 2023
WOPRAI
Market Predictions Driven by AI
- Website: https://www.woprai.c ... ps://www.woprai.com/
- Email: support@woprai.com